thumbnail image
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
  • Home
  • About Us
  • Deal Team
  • Portfolio
  • News
  • Contact Us
    •  

       

       

      XIAODI SU, Ph.D.

      Vice President

    • Xiaodi Su, Ph.D., is a Vice President with Lilly Asia Ventures (LAV). Prior to joining LAV, Xiaodi was a Life Science Specialist at L.E.K., where she led and supported more than 15 projects focusing on pharmaceutical and medtech sectors. Xiaodi holds a Ph.D. in immunology and microbial pathogenesis from the Weill Cornell Graduate School of Medical Sciences and B.S. in biology from Fudan University.

    Company

     

    Shanghai

    Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.

     

     

    Hong Kong

    Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong

     

     

    US

    2730 Sand Hill Road, Suite 130, Menlo Park, CA

    copyright © 2018 Lilly Asia Ventures all rights reserved.

    沪ICP备12003647号

    沪公网安备 31010102005458号

      All Posts
      ×
      LillyAsiaVentures
      Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
      http://user-assets.sxlcdn.com/images/315509/FnksTvTDur7jpExbqYminmtjWgoM.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More